We are live on ! Find out more
PP

PDT Partners Portfolio holdings

AUM $1.69B
1-Year Est. Return 74.01%
This Fund
S&P 500
This Quarter Est. Return
+10.36%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$1.05B
AUM Growth
-$2.89B
Cap. Flow
-$2.96B
Cap. Flow %
-281.28%
Top 10 Hldgs %
16.51%
Holding
1,419
New
160
Increased
195
Reduced
212
Closed
815

Top Buys

Rank Stock Value
1
BAX icon
Baxter International
BAX
+$19.4M
2
BRCM
BROADCOM CORP CL-A
BRCM
+$19.4M
3
MON
Monsanto Co
MON
+$17.8M
4
ECL icon
Ecolab
ECL
+$17.1M
5
VC icon
Visteon
VC
+$13M

Top Sells

Rank Stock Value
1
YHOO
Yahoo Inc
YHOO
+$69.1M
2
GILD icon
Gilead Sciences
GILD
+$59.1M
3
MRK icon
Merck
MRK
+$54.1M
4
WFC icon
Wells Fargo
WFC
+$53.8M
5
X
US Steel
X
+$52.6M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 15.13%
2 Technology 13.74%
3 Healthcare 12.34%
4 Financials 12.02%
5 Industrials 7.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STRA icon
201
Strategic Education
STRA
$1.71B
$1.18M 0.11%
15,877
+1,100
+7% +$77.8K
ALGN icon
202
Align Technology
ALGN
$12B
$1.18M 0.11%
21,027
-70,771
-77% -$3.74M
NICE icon
203
Nice
NICE
$5.29B
$1.18M 0.11%
23,213
-7,809
-25% -$352K
OZK icon
204
Bank OZK
OZK
$5.49B
$1.17M 0.11%
30,900
-25,025
-45% -$874K
ZD icon
205
Ziff Davis
ZD
$1.9B
$1.17M 0.11%
+21,735
New +$1.05M
CELG
206
DELISTED
Celgene Corp
CELG
$1.17M 0.11%
10,456
-60,878
-85% -$6.42M
ENPH icon
207
Enphase Energy
ENPH
$4.84B
$1.17M 0.11%
81,586
+27,586
+51% +$344K
TREE icon
208
LendingTree
TREE
$544M
$1.17M 0.11%
+24,121
New +$998K
ABMD
209
DELISTED
Abiomed Inc
ABMD
$1.17M 0.11%
30,600
-3,800
-11% -$120K
IRDM icon
210
Iridium Communications
IRDM
$4.85B
$1.15M 0.11%
117,436
+84,436
+256% +$790K
MTOR
211
DELISTED
MERITOR, Inc.
MTOR
$1.14M 0.11%
+75,400
New +$957K
HA
212
DELISTED
Hawaiian Holdings, Inc.
HA
$1.14M 0.11%
+43,760
New +$826K
ASRT
213
DELISTED
Assertio
ASRT
$1.13M 0.11%
1,171
+39
+3% +$35.6K
PAY
214
DELISTED
Verifone Systems Inc
PAY
$1.12M 0.11%
30,127
-69,650
-70% -$2.45M
CRUS icon
215
Cirrus Logic
CRUS
$6.74B
$1.12M 0.11%
47,500
+9,400
+25% +$189K
ANIP icon
216
ANI Pharmaceuticals
ANIP
$1.77B
$1.11M 0.11%
19,700
+3,900
+25% +$172K
NXPI icon
217
NXP Semiconductors
NXPI
$68B
$1.11M 0.11%
14,480
PIPR icon
218
Piper Sandler
PIPR
$5.14B
$1.09M 0.1%
75,236
+3,600
+5% +$49.4K
INFO
219
DELISTED
IHS Markit Ltd. Common Shares
INFO
$1.09M 0.1%
+41,342
New +$1.02M
HUM icon
220
Humana
HUM
$46.7B
$1.09M 0.1%
7,600
FFIN icon
221
First Financial Bankshares
FFIN
$4.97B
$1.09M 0.1%
72,884
-8,516
-10% -$127K
BFH icon
222
Bread Financial
BFH
$4.21B
$1.09M 0.1%
4,761
-50,452
-91% -$11M
IPGP icon
223
IPG Photonics
IPGP
$3.89B
$1.09M 0.1%
14,500
+1,100
+8% +$78.3K
GATX icon
224
GATX Corp
GATX
$6.55B
$1.08M 0.1%
18,848
-4,148
-18% -$247K
PDLI
225
DELISTED
PDL BioPharma, Inc.
PDLI
$1.07M 0.1%
139,465
-454,034
-77% -$3.59M

Similar funds

PDT Partners's Q4 2014 Portfolio in Review

As of Q4 2014, PDT Partners held 1,419 positions worth $1.05B, down 73% from $3.94B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

PDT Partners withdrew a net $2.96B in Q4 2014, closing 815 positions and reducing 212 holdings. Its most notable exit was Gilead Sciences, an estimated $59.1M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, up from 13% a quarter earlier, followed by Technology and Healthcare.

Against the trend, PDT Partners opened a new position in Baxter International worth $19.8M.

  • PDT Partners's largest Q4 2014 buy was Baxter International: 498,449 shares worth $19.8M.
  • PDT Partners added most to Visteon in Q4 2014, an estimated $13M increase.
  • PDT Partners's biggest Q4 2014 reduction was Yahoo Inc, cutting an estimated $69.1M.
  • PDT Partners fully exited Gilead Sciences in Q4 2014, selling an estimated $59.1M.
  • PDT Partners's ten largest holdings make up 17% of its $1.05B portfolio in Q4 2014.
  • PDT Partners opened 160 new positions and closed 815 in Q4 2014.
  • PDT Partners's portfolio value fell 73% quarter-over-quarter to $1.05B.

Based on PDT Partners's 13F filing for Q4 2014, filed 17 Feb 2015.